elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38155649-D263509E-20F9-462B-8D20-D957AA6EE684
Q38155649-D263509E-20F9-462B-8D20-D957AA6EE684
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38155649-D263509E-20F9-462B-8D20-D957AA6EE684
Molecular target therapy for bone metastasis: starting a new era with denosumab, a RANKL inhibitor.
P698
Q38155649-D263509E-20F9-462B-8D20-D957AA6EE684
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38155649-D263509E-20F9-462B-8D20-D957AA6EE684
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d922531e3390a40a8932b4def9e521f58ea1cca6
P698
24161019
http://www.w3.org/2001/XMLSchema#string